Major histocompatibility complex antigen-binding groove (MHC groove)

The Major Histocompatibility Complex (MHC) antigen-binding groove is a specialized structural domain located on the extracellular surface of MHC Class I and Class II molecules, serving as the primary platform for antigen presentation to T-cell receptors (TCRs) (StatPearls, 2023). In MHC Class I molecules, the groove is formed by the alpha-1 and alpha-2 helices and is closed at both ends, typically binding short peptides of 8-10 amino acids, whereas the MHC Class II groove is formed by alpha-1 and beta-1 domains and is open-ended, accommodating longer peptides (NCBI, 2022). This site is fundamental to the adaptive immune response, facilitating the recognition of viral, bacterial, and tumor-derived antigens, as well as maintaining self-tolerance. Therapeutic targeting of the MHC groove includes the use of glatiramer acetate to compete with myelin-derived peptides in multiple sclerosis and the development of MHC-peptide blockers for other autoimmune conditions (PubMed, 2021). Conversely, certain drugs like abacavir can bind non-covalently within the groove, altering the repertoire of presented self-peptides and triggering life-threatening hypersensitivity reactions in genetically susceptible individuals (Nature, 2012). Understanding the structural dynamics of the MHC groove is essential for developing targeted immunotherapies and predicting adverse drug reactions in personalized medicine.

Other names

Peptide-binding cleftMHC binding pocketHLA antigen-binding grooveMHC peptide-binding grooveAntigen-binding site

Competitive inhibition of peptide binding or allosteric modification of the peptide-binding repertoire to modulate T-cell recognition.